Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
South Korea · Delayed Price · Currency is KRW 6,100.00
+180.00 (3.04%)
May 21, 2026, 11:10 AM KST
Vaxcell-Bio Therapeutics Market Cap
Vaxcell-Bio Therapeutics has a market cap or net worth of 137.68 billion as of May 20, 2026. Its market cap has decreased by -27.63% in one year.
Market Cap
137.68B
Enterprise Value
99.64B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6,100.00
Market Cap Chart
Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has decreased from 160.24B to 137.68B, a decrease of -14.08%. That is a compound annual growth rate of -2.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 143.96B | -38.04% |
| Dec 30, 2025 | 232.34B | -3.12% |
| Dec 30, 2024 | 239.82B | -53.54% |
| Dec 28, 2023 | 516.20B | -0.71% |
| Dec 29, 2022 | 519.87B | -21.31% |
| Dec 30, 2021 | 660.68B | -73.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeoImmuneTech | 247.66B |
| Bioneer | 236.68B |
| EASY BIO,Inc. | 227.60B |
| Genexine | 216.48B |
| JETEMA, | 213.58B |
| Macrogen | 157.85B |
| MedPacto | 148.24B |
| ENCell | 134.55B |